Sensorimotor and cognitive function of a NEFLP22S mutant model of Charcot–Marie–Tooth disease type 2E

Charcot–Marie–Tooth (CMT) disease is the most frequently encountered hereditary disease causing sensorimotor neuropathies and slowly progressive muscle weakness and atrophy. The P22S mutation of the NEFL gene encoding the light polypeptide neurofilament (NFL) is associated with CMT. To understand more clearly the pathogenesis of sensorimotor dysfunction in CMT, we generated transgenic mice with the NEFLP22S mutation under the tet-off tetracycline regulated system with involvement of the Thy1 neuron-specific promoter. NEFLP22S transgenic mice exhibited extended duration of the hindlimb clasping response and gait anomalies, as well as sensorimotor deficits in stationary beam and suspended bar tests. In addition, the NEFLP22S mice were deficient in the reversal phase of left–right discrimination learning in a water maze. This model mimics some aspects of human CMT pathology and provides an opportunity of ameliorating CMT symptoms with experimental therapies.

Research highlights▶ We generated a new transgenic mice expressing the NEFLP22S gene to understand more clearly the pathogenesis in CMT. ▶ The NEFLP22S transgenic mice exhibited sensorimotorimpairments and cognitive deficits. ▶ This model mimics some aspects of human CMT pathology and provides an opportunity of ameliorating CMT symptoms with experimental therapies.